Abstract
been detected in some non-hepatic cells; however, the details of extrahepatic replication remain 23 unknown. These observations suggest the possibility that miRNAs other than miR-122 can support 24 efficient replication of HCV-RNA in non-hepatic cells. Here, we identified a number of such miRNAs 25 and show that they could be divided into two groups: those that bind HCV-RNA at two locations 26 (miR-122 binding sites I and II), in a manner similar to miR-122 (miR-122-like), and those that target a 27 single site that bridges sites I and II and masking both G28 and C29 in the 5'UTR (non-miR-122-like).
28
Although the enhancing activity of these non-hepatic miRNAs were lower than those of miR-122, 29 substantial expression was detected in various normal tissues. Furthermore, structural modeling 30 indicated that both miR-122-like and non-miR-122-like miRNAs not only can facilitate the formation of 31 an HCV IRES SLII but also can stabilize IRES 3D structure in order to facilitate binding of SLIII to the 32 ribosome. Together, these results suggest that HCV facilitates miR-122-independent replication in 33 non-hepatic cells through recruitment of miRNAs other than miR-122. And our findings can provide a 34 more detailed mechanism of miR-122-dependent enhancement of HCV-RNA translation by focusing 35 on IRES tertiary structure.
37
Author summary 38 One of the determinants for tissue tropism of hepatitis C virus (HCV) is miR-122, a liver-specific 39 microRNA, which is required for efficient propagation. Recently, it has been reported that interaction of 40 miR-122 with the 5'UTR of HCV contributes to the folding of a functional IRES structure that is 41 required for efficient translation of viral RNA. In this study, we examined the minimum motifs in the 42 seed region of miRNAs required for the enhancement of HCV replication. As a result, we found two 43 groups of non-hepatic miRNAs: "miR-122-like miRNAs" that can bind HCV-RNA at two locations in 44 a manner similar to miR-122, and "non-miR-122-like miRNAs" that target a single site that masking
Introduction

53
Hepatitis C virus (HCV) infects over 71 million people worldwide and is a major cause of chronic 54 hepatitis, liver cirrhosis and hepatocellular carcinoma [1] . One of the most important host factors for 55 HCV infection is a liver-specific microRNA (miRNA), miR-122 [2] . On the other hand, chronic 56 infection with HCV is often associated with extrahepatic manifestations such as mixed 57 cryoglobulinemia, B-cell lymphoma, thyroiditis, and diabetes mellitus [3] . Supported by clinical 58 observations, low levels of replication of HCV-RNA were detected in PBMCs and neuronal tissues in 59 chronic hepatitis C patients [4, 5] and the treatment of chronic hepatitis C patients who developed B cell 60 lymphoma by direct-acting antivirals for HCV resulted in the clearance of HCV and lymphoma [6] . 61 These observations suggest that the replication of HCV in non-hepatic cells can be established in 62 miR-122-deficient condition. 63 In general, miRNAs negatively regulate translation of target mRNA through interaction with the 3'UTR 64 in a sequence-specific manner. In this way, miR-122 regulates the expression of genes involved in the 65 maintenance of liver homeostasis, including lipid metabolism, iron metabolism, and carcinogenesis [7, 66 8]. In contrast, miR-122 has also been shown to stabilize HCV-RNA [9] and enhance internal ribosome and Xrn2, and stabilizes the HCV-RNA interaction [16] [17] [18] . Upon HCV infection, the interaction 75 between miR-122-miRISC and HCV-RNA further results in the sequestration of miR-122 from host 76 mRNA targets, a phenomenon known as the "sponge effect", which may be responsible for the 77 long-term oncogenic potential of HCV infection [19] . Recently, it has been reported that miR-122 has 78 an RNA chaperone-like function that induces the folding of the HCV IRES such that in it can readily 79 associate with the 80S ribosome for efficient translation [20, 21] . The functional HCV IRES consists of 80 three parts: the long arm, the short arm and the body. In the liver, HCV hijacks the translating 80S 81 ribosome by using miR-122 to alter the fold of the IRES body in order to bind to the 40S platform [22] . 
Results
111
Interactions between miR-122 and 5'UTR required for enhancement of HCV-RNA replication 112 The direct interaction of two molecules of miR-122 with the 5'UTR is known to be essential for 113 efficient HCV-RNA replication in hepatocytes ( Fig 1A) . One miR-122 molecule binds the HCV-RNA Fig 1C) . In contrast, mutation of positions 3 to 7 severely impaired HCV-RNA replication. Mutation of 124 positions 2 and 15 resulted in 3-fold and 13.5-fold increase in HCV-RNA replication relative to control 125 miRNA, respectively. We also examined whether the interaction of miR-122 at nucleotide positions 3-7 126 in the seed region (GAGUG motif, red characters in Fig 1A) was sufficient to enhance HCV-RNA RNA shown in red in Fig 1A) significantly reduced infectious titers to less than 20% of wild type (Fig   138   1D ). Interestingly, HCV mutants C2G, C3G, A21U, G28C, C29G, C30G, U36A, C37G, C42G, and and 5-fold, respectively, while that of mutants possessing a single mutation in the GAGUG motif, 186 miR-504-3p-mt6, miR-574-5p-mt5 and miR-1236-5p-mt5 (Fig 2B) , exhibited no enhancement ( Fig 3A) enhanced viral replication upon infection with HCV (Fig 3B) . Interestingly, not only the (Fig 3A) exhibited no effect on HCV-RNA replication upon infection with HCV (Fig   221   3B ). These results suggest that miRNAs binding to a single site masking both G28 and C29 in the 222 5'UTR with a 7-nucleotide match are able to enhance HCV-RNA replication. We denote this binding 223 mode as "non-miR-122 like".
225
Natural non-miR-122-like miRNAs enhance HCV-RNA replication.
226
To find natural non-miR-122-like miRNAs, we screened human miRNAs masking G28 and C29 227 between stem loop I and II of HCV RNA with at least a 7-nucleotide match in the seed region. In this 228 way, two non-miR-122-like candidates (miR-25-5p and miR-4730), with 7 and an 8-nucleotide 229 matches, respectively, were identified ( Fig 3C and S3A Fig) . In addition, we used miR-652-3p, with a 230 6-nucleotide match, as a negative control (Fig 3C and S3A Fig) . miR-652-3p, which showed no effect on viral replication (Fig 3D) . These results suggest that 
302
In this study, we have shown that not only miR-122-like miRNAs but also non-miR-122-like miRNAs 303 can enhance HCV-RNA translation (S5B Fig) and replication. (Fig 3D) alter the IRES structure. In contrast, binding of a negative control (miR-652-3p), with only a 6 310 nucleotide match, is predicted not to alter the IRES structure favorably (Fig 3D) . In order to test these 311 hypotheses, we docked representative miRNAs to HCV-RNA, and carried out Replica-Exchange 312 Molecular Dynamics, which can thoroughly sample the resulting conformational space. Specifically, we (Fig 5A, top) , and the spatial distribution of the body and short arm Although non-miR-122-like miR-652-3p can interact with the HCV 5'UTR via G28 and C29, which 383 promotes the formation of the SLII structure based on 2D predictions, it did not enhance HCV RNA 384 replication ( Fig 3D) . We therefore focused on the 3D structural dynamics of the 385 HCV-RNA:miRNA:Ago2 complex. Our 3D structural modeling suggested the importance of 386 conformational stability of the IRES body structure for efficient translation (Fig 5A and 5B) We also observed that, in the presence of either miR-122-like or non-miR-122-like miRNAs, the 399 emergence of the G28A mutation in HCV was suppressed (Fig 4) Analysis of HCV IRES translation activity. In vitro transcribed JFH1-NlucSec GND-SGR RNA (5 522 µg) was electroporated together with Fluc RNA (2 µg) as described above and plated on DMEM 523 containing 10% FBS. Each 3 h post-electroporation, the culture media were harvested and Nanoluc 524 activity was determined in 10 µl aliquots of culture medium using a Nano-Glo TM Luciferase Assay 525 System (Promega). To normalize the electroporation efficiency, each cell was lysed in 50 µl of reporter 526 lysis buffer (Promega) at 9 h post-electroporation and luciferase activity was measured in 10 µl aliquots 527 of the cell lysates using a Luciferase Reporter Assay System (Promega). (residues 1-289), miRNA-122 (Fig 1) , miR-504-3p (Fig 2) , miR-1236-5p, miR-574-5p, miR-25-5p (Fig 537 3), miR-4730 and miR-652-3p, respectively. In order to predict the intact structures of HCV-miRNA 538 complex, we utilize the cryo-EM structure of HCV (PDB ID: 5A2Q) as restraints to perform iFoldRNA 539 simulation [29, 30] . iFoldRNA is an automatic and accurate RNA 3D structure prediction tool, which is 540 developed on the basis of discrete dynamics simulation (DMD) [31, 32] . Distances between C1' atoms 541 in 5A2Q are extracted from its 3D structure as restraints to facilitate the RNA modeling by iFoldRNA.
542
iFoldRNA first builds a ring structure composed of all residues in the complex. Then, it conducts a 543 10000-step initial molecular dynamics simulation to build a preliminary structure. Next, iFoldRNA 
